Call for “Expression of Interest”
March 2026
The Novartis Foundation and the Novartis US Foundation are non-profit organizations, based respectively in Switzerland and the US. We focus on the world’s most pressing health challenges, cardiovascular disease and health inequities, which means widening the lens from a narrow focus on healthcare delivery to a panoramic vision of improving health in populations at large.
This Call seeks to identify the most innovative and impactful approaches to advancing cardiovascular health for women, with a focus on generating meaningful social impact and without any commercial intent. Our aim is to accelerate early detection of cardiovascular risk in women, reduce inequities in diagnosis, treatment, and outcomes, strengthen gender responsive health system design, and develop scalable, sustainable models that can be adapted across diverse healthcare systems. As this initiative is undertaken in the interest of public health, no remuneration will be provided for submitted ideas, only the selected proposal (Final Award) will receive funding and implementation support, as per the rules of this Call.
No product promotion will be linked to funding, and transparent governance as well as conflict of interest disclosure will be required.
Background
Cardiovascular disease remains the leading cause of death among women worldwide. Yet women continue to face delayed diagnosis, atypical symptom recognition, underrepresentation in research, and structural barriers to health and care.
Leading bodies such as the American Heart Association and the European Society of Cardiology have emphasized the urgent need for earlier action and equity-centered system redesign (1). Despite strong clinical advances, scalable and sustainable social innovation models tailored to women’s cardiovascular health remain limited.
The Novartis Foundation has pioneered the CARDIO4Cities initiative to transform cardiovascular health and care through data driven insights, multisector collaboration, and locally embedded implementation. Building on the learnings and infrastructure generated through CARDIO4Cities, the Novartis Foundations now seek to partner with organizations to apply and adapt these approaches with a dedicated focus on women’s cardiovascular health, addressing persistent gender gaps through innovative, equitable, and scalable solutions.
In this additional focus area, we seek to catalyze high-potential models capable of driving sustainable systems change, using innovative interventions and advanced technologies such as agentic AI.